OTCPK:ARLZQ - Post by User
Comment by
snootchybootchyon May 09, 2017 4:09pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
88 Views
Post# 26222730
RE:RE:RE:RE:88 Cents tomorrow
RE:RE:RE:RE:88 Cents tomorrowbiggerr wrote: actually their guidance could be conservative because at $10/month Yosprala is just about the same price as regular aspirin but with the PPI in it to prevent aspirin from burning a hole in your stomach. They could easily get 1 million users @ $120/year
I tihnk you read that incorrectly. That $10/month is just the co-pay.
Been too busy today to listen to the conference call but the financials were surprisingly good. The cash burn has also been cut more than I thought and gives us time to develop the market for Zontivity and increase uptake of Yosprala at the new reduced prices. Mr. Adams has alot of skin in the game so he is highly motivated to create shareholder value. Looking forward to listening to the conference call when I get home.